香港股市 將在 46 分鐘 開市

沃森生物 (300142.SZ)

Shenzhen - Shenzhen 延遲價格。貨幣為 CNY。
加入追蹤清單
13.45-0.11 (-0.81%)
收市：03:04PM CST
全螢幕
前收市價13.56
開市13.92
買盤13.45 x 0
賣出價13.46 x 0
今日波幅13.39 - 13.60
52 週波幅13.13 - 29.27
成交量9,957,045
平均成交量17,017,026
市值21.769B
Beta 值 (5 年，每月)0.69
市盈率 (最近 12 個月)84.06
每股盈利 (最近 12 個月)0.16
業績公佈日無
遠期股息及收益率0.01 (0.07%)
除息日2024年5月30日
1 年預測目標價20.00
  • Reuters

    FOCUS-China's drugmakers can't sell mRNA shots but haven't quit yet

    China's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA technology, but they face a tough path, crimped by a lack of revenue. Three Chinese companies - Walvax Biotechnology, CSPC Pharmaceutical Group and Stemirna Therapeutics - came up with mRNA vaccines that won limited emergency approvals in Asia. However, Walvax and CSPC are not currently manufacturing three of their China market shots, a China health official told Reuters.